Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

University of Edinburgh Invests £1.2M in NMR and Mass Spectroscopy Instrumentation

Published: Friday, April 25, 2014
Last Updated: Friday, April 25, 2014
Bookmark and Share
‘Instantaneous’ turnover of samples will benefit research efforts.

The University of Edinburgh has made a £1.2 million investment in some of the world's most advanced Nuclear Magnetic Resonance (NMR) and Mass Spectroscopy instrumentation to further consolidate its position as a 'centre of excellence' for its acclaimed research in cutting-edge molecular science.

The investment, funded by Core Capability EPSRC (Engineering and Physical Sciences Research Council) and the University of Edinburgh, will support the installation of NMR and Mass Spectroscopy instrumentation, providing the chemical sciences industry with one of the most advanced facilities in Europe, capable of handling an array of molecular constituents, across a broad spectrum of chemical and proteomic sampling.

Moreover, it heralds a new frontier in NMR and Mass Spectroscopy by offering greater efficiencies - higher sensitivity, shorter measurement times, high throughput, better accuracy and superior characterization. For example, Throughputs by Ingenza, a biocatalyst and bioprocess development company, serving the pharmaceutical, food, fine chemical and biofuel industries, claims that the new NMR spectroscopy ‘provides an almost instantaneous turnover of samples which is a huge benefit to research efforts.’

Welcoming the investment, Professor Eleanor Campbell, Head of the School of Chemistry, University of Edinburgh said: “This latest investment in Nuclear Magnetic Resonance and Mass Spectroscopy further enhances our capability to support the chemical sciences and pharma communities.

We now provide full access to the latest analytical instruments and expertise, and I'm confident we'll see fruitful national and global collaboration, given the University of Edinburgh's historic legacy as a centre of excellence in this field and also for our students and researchers to take their expertise into the wider world.”

Edinburgh Research and Innovation (ERI), the commercialization arm of the University of Edinburgh, will look to develop commercial opportunities for the instrumentation. Stuart Duncan, ERI's Business Development Executive at the School of Chemistry comments: "This investment builds on our excellent track record in making our world class research base available to the wider chemical sciences community and on our ongoing collaboration and equipment-sharing with the University of St Andrews who have made a similar scale investment in complementary equipment. It will be of interest to many different businesses which need access to these important analytical techniques."

The investment has been warmly welcomed by Chemical Sciences Scotland, the partnership of industry with Scotland’s world-renowned academic sector and government agencies.

Its chairman, Sandy Dobbie, said: “Collaboration, in particular between industry and academia, is a key component if we are to grow Scotland’s chemical sciences sector. Today’s announcement is another great example of how Scotland’s academic sector is helping to support research within industry to improve manufacturing processes and develop new products.”

Head of chemical sciences at Scottish Enterprise, Caroline Strain, added: “Encouraging higher levels of innovation amongst our chemical sciences companies is a key priority for us, particularly as we strive to become leading players in sustainable manufacturing. I welcome today’s announcement by the University of Edinburgh, and we will continue to work closely with them to help realize our collective ambitions.”

NMR is a sophisticated and powerful analytical technology that is used by many disciplines of scientific research, medicine and industry. NMR delivers structural determination and identification of a range of materials including small organic/inorganic molecules, steroids, antibiotics, carbohydrates, lipids, polypeptides, proteins, nucleic acids and complex mixtures.

Mass Spectrometry, too, is a powerful analytical tool which can help to answer a wide range of biological and chemical questions.

For example, the identification and characterization of proteins - of interest to researchers involved in the discovery of new therapeutic targets and to the biopharmaceutical industry for the characterization of new potential products.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
Wednesday, May 25, 2016
Salt Gene Could Help Cut Heart Disease
Scientists from the University of Edinburgh find that removal of a gene linked with high blood pressure causes a strong appetite for salt.
Wednesday, March 30, 2016
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Monday, November 30, 2015
Garlic Could Aid Cystic Fibrosis Fight
A chemical in garlic kills bacteria that cause deadly infections in people with cystic fibrosis, University of Edinburgh research shows.
Monday, March 02, 2015
Bowel Disease Gene Discovery
Genetic changes that occur in patients with the bowel condition Crohn’s disease could hold clues to fighting the illness.
Wednesday, August 27, 2014
Risk of Brain Injury is Genetic
Link between injury to the developing brain and common variation in genes identified.
Tuesday, May 20, 2014
Why Stem Cells Need to Stick with their Friends
Scientists have identified a core set of functionally relevant factors which regulates embryonic stem cells’ ability for self-renewal.
Tuesday, November 12, 2013
Research Make Light Work of Fixing Broken Bones
Artificial bone, created using stem cells and a new lightweight plastic, could soon be used to heal shattered limbs.
Wednesday, February 13, 2013
Microarray-based Assays for Blood Typing and Diagnosis of Infectious Diseases
University of Edinburgh scientists are developing multiplex microarray using Tecan’s LS Reloaded™ laser scanner.
Friday, April 17, 2009
Edinburgh Scientists Identify Factor that Poises Stem Cells for Specialization
Researchers show that mouse embryonic stem cells need the protein FGF4 to become competent to be converted into specialized cell types.
Friday, August 03, 2007
University of Edinburgh Purchases Arrayjet Microarray Spotter
The spotter increases throughput capacity and performance essential to meet the increasing demand for high quality microarrays.
Tuesday, June 20, 2006
"Land of the Ever-Young" Gene Reprogrammes Cells
A team of scientists at the Institute for Stem Cell Research investigated the switching of adult cell types into embryonic stem cells after cell fusion.
Monday, June 19, 2006
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!